These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 623085)
1. Case-control studies in the evaluation of drug-induced illness. Jick H; Vessey MP Am J Epidemiol; 1978 Jan; 107(1):1-7. PubMed ID: 623085 [No Abstract] [Full Text] [Related]
2. Epidemiological observation on drug-induced illness. Jick H Curr Top Pathol; 1980; 69():1-15. PubMed ID: 7016466 [No Abstract] [Full Text] [Related]
3. Case-control studies in the assessment of drug safety. Vessey MP Acta Med Scand Suppl; 1984; 683():29-33. PubMed ID: 6588736 [TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions: the need for detection and control. Cluff LE Am J Epidemiol; 1971 Nov; 94(5):405-8. PubMed ID: 5120538 [No Abstract] [Full Text] [Related]
6. The importance of postmarketing drug surveillance. Smart AJ; Walters L S Afr Med J; 1992 Dec; 82(6):383-4. PubMed ID: 1465681 [No Abstract] [Full Text] [Related]
7. Adverse drug reaction monitoring. The practicalities. Edwards IR Med Toxicol Adverse Drug Exp; 1987; 2(6):405-10. PubMed ID: 3431427 [No Abstract] [Full Text] [Related]
8. Computer analysis of epidemiologic data on effect of drugs on hospital patients. Slone D; Gaetano LF; Lipworth L; Shapiro S; Lewis GP; Jick H Public Health Rep (1896); 1969 Jan; 84(1):39-52. PubMed ID: 4974707 [No Abstract] [Full Text] [Related]
9. Iatrogenic disease: an epidemiologic perspective. Sartwell PE Int J Health Serv; 1974; 4(1):89-93. PubMed ID: 4829900 [No Abstract] [Full Text] [Related]
10. Monitoring adverse reactions to drugs: toward a therapeutic audit. Wade OL; Beeley L Int J Health Serv; 1974; 4(1):109-23. PubMed ID: 4597989 [No Abstract] [Full Text] [Related]
11. [Methodology of epidemiological studies in drug hepatotoxicity]. Plomteux G Sem Hop; 1974 Jun; 50(28):1947-52. PubMed ID: 4374747 [No Abstract] [Full Text] [Related]
12. Complex mixtures and multiple agent interactions: the issues and their significance. Bingham E; Morris S Fundam Appl Toxicol; 1988 May; 10(4):549-52. PubMed ID: 3396786 [No Abstract] [Full Text] [Related]
14. How study of geographic epidemiology of disease can help in detection of adverse drug reactions. Stolley PD Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):679-82. PubMed ID: 1269208 [TBL] [Abstract][Full Text] [Related]
15. The promise of pharmacoepidemiology. Strom BL Annu Rev Pharmacol Toxicol; 1987; 27():71-86. PubMed ID: 3555321 [No Abstract] [Full Text] [Related]
16. Privacy, epidemiology, and record linkage. Br Med J; 1979 Oct; 2(6197):1018. PubMed ID: 519266 [No Abstract] [Full Text] [Related]
17. Web-based intensive monitoring of adverse events following influenza vaccination in general practice. van Balveren-Slingerland L; Kant A; Härmark L Vaccine; 2015 May; 33(19):2283-2288. PubMed ID: 25797367 [No Abstract] [Full Text] [Related]
18. Towards rational drug therapy in old age. The F.E. Williams Lecture 1985. Caird FI J R Coll Physicians Lond; 1985 Oct; 19(4):235-9. PubMed ID: 4067897 [No Abstract] [Full Text] [Related]
19. Post-marketing surveillance: drug epidemiology. Borden EK J Int Med Res; 1981; 9(6):401-7. PubMed ID: 7319130 [TBL] [Abstract][Full Text] [Related]
20. Assuring the safety and efficacy of therapies. Stolley PD Int J Health Serv; 1974; 4(1):131-45. PubMed ID: 4597990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]